Patent classifications
C07D239/26
ORGANIC ELECTROLUMINESCENT ELEMENT
The present invention provides an organic electroluminescent element which comprises: an anode; a cathode; and an organic layer interposed between the anode and the cathodes, wherein the organic layer comprises one or more types of layer from the group consisting of a hole-injection layer, hole-transport layer, light-emitting layer, lifetime enhancement layer, electron-transport layer, and electron-injection layer.
Nonaqueous electrolyte, nonaqueous electrolyte energy storage device, and method for producing nonaqueous electrolyte energy storage device
Provided are a nonaqueous electrolyte capable of providing a nonaqueous electrolyte energy storage device with reduced direct current resistance and an increased capacity retention ratio after charge-discharge cycles, a nonaqueous electrolyte energy storage device including such a nonaqueous electrolyte, and a method for producing such a nonaqueous electrolyte energy storage device. One mode of the present invention is a nonaqueous electrolyte for an energy storage device, containing an additive represented by the following Formula (1) or Formula (2). In Formula (1), R.sup.1 to R.sup.4 are each independently a hydrogen atom or a group represented by —NR.sup.a.sub.2, —OR.sup.a, —SR.sup.a, etc., with the proviso that at least one of R.sup.1 to R.sup.4 is a group represented by —OR.sup.a, —SR.sup.a, —COOR.sup.a, —COR.sup.a, —SO.sub.2R.sup.a, or —SO.sub.3R.sup.a. In Formula (2), R.sup.5 to R.sup.7 are each independently a hydrogen atom or a group represented by —NR.sup.b.sub.2, —OR.sup.b, or —SR.sup.b, with the proviso that at least one of R.sup.5 to R.sup.7 is a group represented by —SR.sup.b. ##STR00001##
Nonaqueous electrolyte, nonaqueous electrolyte energy storage device, and method for producing nonaqueous electrolyte energy storage device
Provided are a nonaqueous electrolyte capable of providing a nonaqueous electrolyte energy storage device with reduced direct current resistance and an increased capacity retention ratio after charge-discharge cycles, a nonaqueous electrolyte energy storage device including such a nonaqueous electrolyte, and a method for producing such a nonaqueous electrolyte energy storage device. One mode of the present invention is a nonaqueous electrolyte for an energy storage device, containing an additive represented by the following Formula (1) or Formula (2). In Formula (1), R.sup.1 to R.sup.4 are each independently a hydrogen atom or a group represented by —NR.sup.a.sub.2, —OR.sup.a, —SR.sup.a, etc., with the proviso that at least one of R.sup.1 to R.sup.4 is a group represented by —OR.sup.a, —SR.sup.a, —COOR.sup.a, —COR.sup.a, —SO.sub.2R.sup.a, or —SO.sub.3R.sup.a. In Formula (2), R.sup.5 to R.sup.7 are each independently a hydrogen atom or a group represented by —NR.sup.b.sub.2, —OR.sup.b, or —SR.sup.b, with the proviso that at least one of R.sup.5 to R.sup.7 is a group represented by —SR.sup.b. ##STR00001##
GPR52 MODULATORS AND METHODS OF USE
The present disclosure relates to compounds of Formula (I) that modulate the activity of G-protein coupled receptor 52 (GPR52), pharmaceutically acceptable salts of compounds of Formula (I), and pharmaceutical compositions thereof. Compounds, pharmaceutical salts of compounds, and pharmaceutical compositions of the present disclosure are directed to methods useful in the treatment or prophylaxis of a neurological disease or disorder and conditions related thereto.
##STR00001##
GPR52 MODULATORS AND METHODS OF USE
The present disclosure relates to compounds of Formula (I) that modulate the activity of G-protein coupled receptor 52 (GPR52), pharmaceutically acceptable salts of compounds of Formula (I), and pharmaceutical compositions thereof. Compounds, pharmaceutical salts of compounds, and pharmaceutical compositions of the present disclosure are directed to methods useful in the treatment or prophylaxis of a neurological disease or disorder and conditions related thereto.
##STR00001##
Organic Compound of Formula (I) for Use in Organic Electronic Devices, a Composition Comprising a Compound of Formula (IV) and at Least One Compound of Formula (IVa) to (IVd), an Organic Semiconductor Layer Comprising the Compound or Composition, an Organic Electronic Device Comprising the Organic Semiconductor Layer, and a Display Device Comprising the Organic Electronic Device
The present invention relates to a compound of formula (I) for use in organic electronic devices, a composition comprising a compound of formula (IV) and at least one compound of formula (IVa) to (IVd), an organic semiconductor layer comprising the compound or composition, an organic electronic device comprising the organic semiconductor layer, and a display device comprising the organic electronic device.
##STR00001##
Organic Compound of Formula (I) for Use in Organic Electronic Devices, a Composition Comprising a Compound of Formula (IV) and at Least One Compound of Formula (IVa) to (IVd), an Organic Semiconductor Layer Comprising the Compound or Composition, an Organic Electronic Device Comprising the Organic Semiconductor Layer, and a Display Device Comprising the Organic Electronic Device
The present invention relates to a compound of formula (I) for use in organic electronic devices, a composition comprising a compound of formula (IV) and at least one compound of formula (IVa) to (IVd), an organic semiconductor layer comprising the compound or composition, an organic electronic device comprising the organic semiconductor layer, and a display device comprising the organic electronic device.
##STR00001##
NAPHTHOQUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS
Disclosed herein are naphthoquinone derivative compounds of the formula shown below, compositions thereof, and methods of using such compounds and compositions for treating or suppressing oxidative stress disorders and/or neurodegenerative disorders and/or for inhibiting ferroptosis.
##STR00001##
Polycyclic compound and organic light emitting element comprising same
Provided is a compound of Chemical Formula 1: ##STR00001## where A and B each independently is a substituted or unsubstituted aryl group, a substituted or unsubstituted monocyclic or dicyclic heteroaryl group, a substituted or unsubstituted dibenzofuran group, a substituted or unsubstituted benzonaphthofuran group, a substituted or unsubstituted dibenzothiophene group, a substituted or unsubstituted benzonaphthothiophene group, a substituted or unsubstituted phenoxazine group, a substituted or unsubstituted phenothiazine group, a substituted or unsubstituted phenanthroline group, a substituted or unsubstituted benzoquinoline group, a substituted or unsubstituted arylamine group, a substituted or unsubstituted silyl group, or a substituted or unsubstituted phosphine oxide group, or one of the following substituents: ##STR00002## and an organic light emitting device including the same.
Polycyclic compound and organic light emitting element comprising same
Provided is a compound of Chemical Formula 1: ##STR00001## where A and B each independently is a substituted or unsubstituted aryl group, a substituted or unsubstituted monocyclic or dicyclic heteroaryl group, a substituted or unsubstituted dibenzofuran group, a substituted or unsubstituted benzonaphthofuran group, a substituted or unsubstituted dibenzothiophene group, a substituted or unsubstituted benzonaphthothiophene group, a substituted or unsubstituted phenoxazine group, a substituted or unsubstituted phenothiazine group, a substituted or unsubstituted phenanthroline group, a substituted or unsubstituted benzoquinoline group, a substituted or unsubstituted arylamine group, a substituted or unsubstituted silyl group, or a substituted or unsubstituted phosphine oxide group, or one of the following substituents: ##STR00002## and an organic light emitting device including the same.